New therapeutic options for breast cancer during pregnancy

Breast Care

Volumn 3, Issue 3, 2008, Pages 171-176

  Loibl, Sibylle ^a,b  

^a German Breast Group   (Germany)

^b c/o GBG Forschungs GmbH ^*  (Germany)

Author keywords

Breast cancer; Chemotherapy; Pregnancy; Radiation

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BREAST CANCER RESISTANCE PROTEIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GADOLINIUM; GLUCOCORTICOID; GLYCOPROTEIN P; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; ISOSULFAN BLUE; LAPATINIB; METHOTREXATE; NAVELBINE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ONDANSETRON; PACLITAXEL; PALONOSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEROTONIN 3 ANTAGONIST; TAXANE DERIVATIVE; TECHNETIUM SULFUR COLLOID TC 99M; TRASTUZUMAB; TROPISETRON; UNINDEXED DRUG; VINCA ALKALOID;

ADJUVANT THERAPY; ANAPHYLAXIS; ANEMIA; BLOOD TRANSFUSION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CESAREAN SECTION; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIALYSIS; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FETUS DISTRESS; FETUS MALFORMATION; FOLLOW UP; HEART FAILURE; HUMAN; HYDROCEPHALUS; KIDNEY FAILURE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAMMOGRAPHY; MULTIPLE CYCLE TREATMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOHYDRAMNIOS; OVARY CANCER; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VAGINA BLEEDING; VAGINAL DELIVERY;

EID: 46849087604     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000136002     Document Type: Review

References (65)

1. Ahn BY, Kim HH, Moon WK, Pisano ED, Kim HS, Cha ES, Kim JS, Oh KK, Park SH: Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J Ultrasound Med 2003;22:491-497.
2. Liberman L, Giess CS, Dershaw DD, Deutch BM, Petrek JA: Imaging of pregnancy-associated breast cancer. Radiology 1994;191:245-248.
3. Mazonakis M, Varveris H, Damilakis J, Theoharopoulos N, Gourtsoyiannis N: Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 2003;55:386-391.
4. Ebert U, Loffler H, Kirch W: Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207-220.
5. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-1351.
6. Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, Lejeune C, Martin PM, Piana L: Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 1997;72:720-727.
7. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-1351.
8. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A: Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003;98:1055-1060.
9. Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP, Langmuir V, Rugo HS: Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 2005;23:792-799.
10. Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM: Pregnancy and breast cancer: a population-based study. Virchows Arch 2003;443:44-50.
11. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA: Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005;23:4192-4197.
12. Woo JC, Yu T, Hurd TC: Breast cancer in pregnancy: a literature review. Arch Surg 2003;138:91-98.
13. Aziz S, Pervez S, Khan S, Siddiqui T, Kayani N, Israr M, Rahbar M: Case control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma. Pathol Res Pract 2003;199:15-21.
14. Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nole F, Martinelli G, Goldhirsch A: Very young women (< 35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002;13:273-279.
15. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A: Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003;98:1055-1060.
16. Barthelmes L, Davidson LA, Gaffney C, Gateley CA: Pregnancy and breast cancer. BMJ 2005;330:1375-1378.
17. Duncan PG, Pope WD, Cohen MM, Greer N: Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986;64:790-794.
18. Mazze RI, Kallen B: Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989;161:1178-1185.
19. Kaufmann M, von MG, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P, Untch M, Blohmer JU, Sinn HP, Sittek R, Souchon R, Tulusan AH, Volm T, Senn HJ: International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 2003;21:2600-2608.
20. Kuerer HM, Gwyn K, Ames FC, Theriault RL: Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 2002;131:108-110.
21. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN: Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-861.
22. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-1351.
23. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348-1351.
24. Mondi MM, Cuenca RE, Ollila DW, Stewart JH, Levine EA: Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol 2007;14:218-221.
25. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, Feig BW, Ross MI, Kuerer HM: Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-398.
26. Crivellaro M, Senna G, Dama A, Bonadonna P, Passalacqua G: Anaphylaxis due to patent blue dye during lymphography, with negative skin prick test. J Investig Allergol Clin Immunol 2003;13:71-72.
27. Bradley B, Fleck A, Osei EK: Normalized data for the estimation of fetal radiation dose from radiotherapy of the breast. Br J Radiol 2006;79:818-827.
28. Kal HB, Struikmans H: Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005;6:328-333.
29. Hebert-Croteau N, Freeman CR, Latreille J, Rivard M, Brisson J: A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat 2004;88:187-196.
30. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI: Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 2006;65:1353-1360.
31. Vujovic O, Cherian A, Yu E, Dar AR, Stitt L, Perera F: The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and nodenegative disease, with long term follow-up. Int J Radiat Oncol Biol Phys 2006;66:687-690.
32. Kaufmann M, Hortobagyi GN, Goldhirsch A, Scholl S, Makris A, Valagussa P, Blohmer JU, Eiermann W, Jackesz R, Jonat W, Lebeau A, Loibl S, Miller W, Seeber S, Semiglazov V, Smith R, Souchon R, Stearns V, Untch M, von Minckwitz G: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006;24:1940-1949.
33. Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thurlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A: Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 2000;18:584-590.
34. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-291.
35. Barthelmes L, Davidson LA, Gaffney C, Gateley CA: Pregnancy and breast cancer. BMJ 2005;330:1375-1378.
36. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA: Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005;23:4192-4197.
37. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219-1226.
38. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G: Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992;166:781-787.
39. Woo JC, Yu T, Hurd TC: Breast cancer in pregnancy: a literature review. Arch Surg 2003;138:91-98.
40. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E, III, Schilsky RL, Wood WC, Muss HB, Norton L: Improved outcomes from adding sequential paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with nodepositive primary breast cancer. J Clin Oncol 2003;21:976-983.
41. Mamounas EP, Bryant J, Lembersky B, Fehrenbacher L, Sedlacek SM, Fisher B, Wickerham DL, Yothers G, Soran A, Wolmark N: Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol 2005;23:3686-3696.
42. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C: Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 2005;352:2302-2313.
43. De Santis M, Lucchese A, De CS, Ferrazani S, Caruso A: Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care (Engl) 2000;9:235-237.
44. Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, Genazzani AR: Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 2003;23:5225-5229.
45. Nieto Y, Santisteban M, Aramendia JM, Fernandez-Hidalgo O, Garcia-Manero M, Lopez G: Docetaxel administered during pregnancy for inflammatory breast carcinoma. Clin Breast Cancer 2006;6:533-534.
46. Potluri V, Lewis D, Burton GV: Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 2006;7:167-170.
47. Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer JM, Goldwasser F: Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2007.
48. Arceci RJ, Croop JM, Horwitz SB, Housman D: The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A 1988;85:4350-4354.
49. Smit JW, Huisman MT, van TO, Wiltshire HR, Schinkel AH: Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999;104:1441-1447.
50. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N: Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353:1673-1684.
51. Slamon DJ, Eiermann W, Robert N, et al.: Phase III trial comparing AC-T with AC-TH and with TCH in the adjuvant treatment of Her2 positive early breast cancer patients: first interim efficacy analysis. Breast Cancer Res Treat 2005;89(Suppl 1):abstr 5.
52. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659-1672.
53. Waterston AM, Graham J: Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 2006;24:321-322.
54. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA: Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 2005;6:354-356.
55. Watson WJ: Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 2005;105:642-643.
56. Kelly H, Graham M, Humes E, Dorflinger LJ, Boggess KA, O'Neil BH, Harris J, Spector NL, Dees EC: Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 2006;7:339-341.
57. Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G: The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004;111:940-943.
58. Aebi S, Loibl S: Breast cancer during pregnancy: medical therapy and prognosis. Recent Results Cancer Res 2008;178:45-55.
59. Watson WJ: Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 2005;105:642-643.
60. Waterston AM, Graham J: Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 2006;24:321-322.
61. Kelly H, Graham M, Humes E, Dorflinger LJ, Boggess KA, O'Neil BH, Harris J, Spector NL, Dees EC: Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer 2006;7:339-341.
62. Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E: Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79-81.
63. Sekar R, Stone PR: Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol 2007;110:507-510.
64. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G: Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy - case report and updated literature review. Reprod Toxicol 2007;23:611-613.
65. Witzel ID, Muller V, Harps E, Janicke F, Dewit M: Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol 2008;19:191-192.